You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Suppliers and packagers for generic pharmaceutical drug: BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Novast Labs BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride CAPSULE;ORAL 217511 ANDA Ingenus Pharmaceuticals, LLC 50742-283-13 120 CAPSULE in 1 CARTON (50742-283-13) 2023-07-04
Ph Health BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride CAPSULE;ORAL 205770 ANDA Endo USA, Inc. 49884-151-54 120 CAPSULE in 1 CARTON (49884-151-54) 2023-03-07
Labs Juvise PYLERA bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride CAPSULE;ORAL 050786 NDA H2-Pharma, LLC 61269-380-12 10 BLISTER PACK in 1 BOX (61269-380-12) / 12 CAPSULE in 1 BLISTER PACK 2023-10-01
Labs Juvise PYLERA bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride CAPSULE;ORAL 050786 NDA H2-Pharma, LLC 61269-381-12 10 BLISTER PACK in 1 BOX (61269-381-12) / 12 CAPSULE in 1 BLISTER PACK 2025-08-18
Labs Juvise PYLERA bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride CAPSULE;ORAL 050786 NDA H2-Pharma, LLC 61269-385-12 1 BLISTER PACK in 1 BOX (61269-385-12) / 120 CAPSULE in 1 BLISTER PACK 2023-07-31
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drugs: Bismuth Subcitrate Potassium, Metronidazole, Tetracycline Hydrochloride

Last updated: July 29, 2025

Introduction

The pharmaceutical landscape requires reliable suppliers for active pharmaceutical ingredients (APIs) such as bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride. These compounds are integral to treating gastrointestinal infections, bacterial diseases, and other medical conditions. Ensuring quality, regulatory compliance, and supply chain stability are critical considerations for pharmaceutical manufacturers and healthcare providers.

This report consolidates information on key suppliers worldwide, emphasizing their capacity, quality standards, compliance credentials, and market position. Understanding the global supplier ecosystem enhances procurement strategies, mitigates supply chain risks, and supports regulatory adherence.


Bismuth Subcitrate Potassium Suppliers

Overview

Bismuth subcitrate potassium (C₆H₄BK₃O₈) is primarily utilized for conditional treatment of peptic ulcers, often in combination therapy for Helicobacter pylori eradication. Its supply chain is concentrated among global manufacturers with expertise in bismuth compounds.

Leading Suppliers

  • Everest Organics Ltd. (India)
    A prominent API manufacturer specializing in bismuth compounds, Everest Organics adheres to WHO-GMP standards and supplies both domestic and international markets. Their bismuth subcitrate potassium meets pharmacopoeial monographs, ensuring quality and consistency [1].

  • Galenica (China)
    Known for its extensive API production, Galenica exports to multiple continents. Their facilities are GMP-certified, and they comply with Chinese regulatory standards, providing reliable supply channels for bismuth subcitrate potassium [2].

  • H.M. Gupta and Company (India)
    This firm supplies high-purity bismuth salts, including subcitrate potassium, with certifications for export markets. Their manufacturing process emphasizes environmental compliance and stringent quality controls [3].

Market Considerations

Due to the specialized nature of bismuth salts, few suppliers operate at significant scales. Buyers should prioritize suppliers with robust quality assurance protocols and regulatory adherence. India and China dominate the supply landscape, highlighting the importance of due diligence to ensure product stability and regulatory compliance in different jurisdictions.


Metronidazole Suppliers

Overview

Metronidazole (C₆H₉N₂O₃) is a nitroimidazole antimicrobial used for anaerobic infections, protozoal diseases, and other bacterial conditions. It enjoys broad manufacturing representation across Asia, Europe, and North America.

Leading Suppliers

  • Hetero Labs Limited (India)
    A prominent API manufacturer with extensive experience producing metronidazole. Hetero adheres to cGMP standards and supplies to global markets, including regulatory approvals in the US, Europe, and India [4].

  • Intas Pharmaceuticals (India)
    This company produces high-quality metronidazole with strict quality control, ISO certification, and documented compliance with international standards. They have supplied large volumes for generic markets worldwide [5].

  • Siegfried AG (Switzerland)
    A European API manufacturer with advanced quality systems, Siegfried supplies metronidazole to multinational pharmaceutical companies. Their manufacturing facilities comply with stringent EU standards [6].

  • Jiangsu Hengrui Medicine Co., Ltd. (China)
    A key Chinese producer known for its cost-effective APIs, with GMP certification and export licenses for metronidazole. They operate at significant scale, supporting global demand [7].

Market Dynamics

Metronidazole manufacturing is well-established across multiple continents, leading to competitive pricing and reliable supply. Buyers should verify GMP compliance, regulatory approvals (FDA, EMA, etc.), and batch consistency when selecting suppliers.


Tetracycline Hydrochloride Suppliers

Overview

Tetracycline hydrochloride (C₂₀H₂₁ClN₂O₈·HCl) is an antibiotic used in treating bacterial infections. This compound's production requires specialized fermentation and chemical synthesis, limiting the number of high-quality manufacturers.

Leading Suppliers

  • HIKAL Limited (India)
    A leading producer in India, HIKAL offers tetracycline hydrochloride conforming to pharmacopoeial standards. They hold GMP and ISO certifications, with verified supply chain integrity [8].

  • Changzhou Qianhong Bio-Pharma Co., Ltd. (China)
    Specializes in antibiotic APIs, including tetracycline hydrochloride, with substantial export volume. Their manufacturing facilities operate under GMP, with exports to Europe, North America, and Asia [9].

  • Novartis AG (Switzerland)
    Historically, Novartis has been involved in tetracycline production, although their focus has shifted towards more modern antibiotics. Nevertheless, they remain an established supplier through legacy supply channels or licensing agreements.

  • United Laboratories (Philippines)
    Provides tetracycline hydrochloride for regional markets, adhering to international quality standards and regulatory compliance.

Supply Chain Notes

Limited high-volume producers can impact market supply, especially during global crises or raw material shortages. Quality assurance remains paramount; buyers should prioritize suppliers with clear GMP certifications and proven regulatory track records.


Regulatory and Quality Considerations

For all API procurement, compliance with regulatory frameworks such as the United States Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.), and WHO standards is vital. Supplier audits, batch-to-batch consistency, stability data, and Good Manufacturing Practice (GMP) certification form the backbone of reliable sourcing.

Moreover, geopolitical factors and trade policies influence supply chains. Importers should verify supplier registration status within local regulatory bodies and conduct routine site audits when feasible.


Market Outlook and Supply Chain Strategies

The global demand for these APIs remains steady owing to their essential therapeutic roles. India and China dominate API manufacturing due to cost competitiveness and manufacturing scale, but diversified sourcing can mitigate geopolitical risks.

Leveraging multiple suppliers, establishing long-term partnerships, and conducting rigorous quality assessments constitute best practices. Additionally, engaging with reputable contract manufacturing organizations (CMOs) can ensure supply continuity.


Key Takeaways

  • India and China are the primary hubs for bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride, offering cost-effective options with established regulatory compliance.
  • Suppliers with GMP, ISO, and pharmacopoeial certifications ensure API quality and regulatory acceptance.
  • The market exhibits high competition, but supply chain stability depends on supplier capacity, compliance, and geopolitical stability.
  • Due diligence, including audits, quality verification, and regulatory validation, is essential before establishing procurement agreements.
  • Diversification across multiple qualified suppliers reduces risk and enhances supply resilience amid global uncertainties.

FAQs

1. How can I verify the regulatory compliance of API suppliers?
Regularly review supplier certifications like GMP, ISO, and pharmacopoeial compliance. Conduct on-site audits or request audit reports and batch testing documentation from suppliers.

2. Are Chinese and Indian API suppliers reliable for global pharmaceutical manufacturing?
Yes, many adhere to international standards such as GMP and ISO. However, due diligence, including audits and verifying regulatory approvals, is essential to ensure quality and compliance.

3. What are the risks associated with a concentrated supply chain for these APIs?
Dependence on limited geographic regions may lead to supply disruptions due to geopolitical tensions, trade restrictions, or raw material shortages. Diversifying sources mitigates such risks.

4. What quality standards should I look for in API suppliers?
Certifications such as GMP, ISO 9001, and compliance with pharmacopoeial standards (USP, EP, BP). Batch release testing, stability data, and regulatory approval evidence are also important.

5. Can APIs be sourced from non-traditional markets?
While less common, some manufacturers in emerging markets meet international quality standards. Verification of certifications and compliance remains critical in such cases.


Sources

  1. Everest Organics Ltd. product catalog.
  2. Galenica API manufacturing overview.
  3. H.M. Gupta and Company certifications.
  4. Hetero Labs Limited official website.
  5. Intas Pharmaceuticals API portfolio.
  6. Siegfried AG regulatory compliance info.
  7. Jiangsu Hengrui Medicine Co., Ltd. API details.
  8. HIKAL Limited API specifications.
  9. Changzhou Qianhong Bio-Pharma Co., Ltd. production standards.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing